HROWM

Harrow Health Inc

• PUBT·5d ago

  Harrow updates financial calendar with upcoming quarterly results release and conference call

• Reuters·04/16 11:01

  HARROW INC - IOPIDINE 1% ASSIGNED PERMANENT J-CODE J2374 BY CMS EFFECTIVE JULY 1, 2026

• PUBT·04/14 14:30

  Harrow selects LogiCare3PL as U.S. distribution partner for ophthalmic products

• Reuters·04/07 12:12

  HARROW INC <HROW.O>: B. RILEY CUTS TARGET PRICE TO $65 FROM $74

• Reuters·03/27 20:07

  Harrow issues $50 million 8.625% senior notes due 2030; offering grows total 2030 notes to $300 million

• Reuters·03/25 20:01

  ProKidney appoints Greg Madison chief commercial officer; senior leadership team expands

• Reuters·03/24 12:15

  HARROW ANNOUNCES ADD-ON OFFERING OF $50.0 MILLION OF SENIOR UNSECURED NOTES TO SUPPORT GROWTH

• Reuters·03/18 11:01

  Harrow to present three abstracts at ASCRS 2026 Annual Meeting

• Reuters·03/04 12:02

  Harrow to present at Leerink Partners 2026 Global Healthcare Conference in Miami

• Reuters·03/03 21:06

  Opaleye Management Inc. reports disposal of Harrow Inc. common shares

• Reuters·03/03 15:42

  BUZZ-U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy

• Reuters·03/03 12:29

  BRIEF-Harrow To Initiate Phase 3 Clinical Trial Seeking To Expand Triesence® Label To Include Ocular Inflammation And Pain Following Cataract Surgery Indication

• Reuters·03/03 12:02

  FDA clears Harrow IND for Phase 3 TRIESENCE cataract surgery trial

• Reuters·03/03 12:00

  HARROW INC - TO INITIATE PHASE 3 STUDY IN Q1 2026

• Reuters·03/03 10:02

  BUZZ-Drugmaker Harrow slumps after forecasting annual revenue below estimates